Manhattan Scientifics, Inc. / Fundamentals
Income statement
- Net revenue
€1.72K - Cost of goods sold
€861.55 - Gross profit
€861.55 - SG&A expenses
€579.82K - R&D expenses
€8.62K - EBITDA
-€677.18K - D&A
€2.13K - EBIT
-€588.44K - Interest expenses
€0.00 - EBT
-€909.80K - Tax expenses
-€167.71K - Net income
-€909.80K
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€321.36K - Changes in working capital
€493.67K - Operating cash flow
-€94.77K - Capex
€0.00 - Other investing cash flow
€87.88K - Net investing cash flow
€91.32K - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
-€8.62K - Other financing cash flow
€0.00 - Net financing cash flow
-€8.62K - Foreign exchange effects
€0.00 - Net change in cash
-€12.06K - Cash at end of period
€32.74K - Free cash flow
-€94.77K
Balance sheet
- Cash and cash equivalents
€32.74K - Cash and short-term investments
€32.74K - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€6.03K - Total current assets
€38.77K - Property, plant & equipment
€0.00 - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€23.26K - Other non-current assets
€1.72K - Total non-current assets
€24.98K - Total assets
€63.75K - Accounts payable
€134.40K - Short-term debt
€51.69K - Other current liabilities
€1.88M - Total current liabilities
€2.08M - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€0.00 - Total liabilities
€2.08M - Common stock
€481.61K - Retained earnings
-€62.85M - Other equity
-€481.61K - Total equity
-€2.02M - Total liabilities and shareholders' equity
€63.75K
Company information
- Market capitalization
€47.70K - Employees
1 - Enterprise Value
€77.93K
Company ratios
- Gross margin
-
50.0% Much better than peer group: 19.6% - EBITDA margin
-
-39,300.0% Much worse than peer group: 40,580.8% - EBIT margin
-
-34,150.0% Much worse than peer group: 66,632.8% - EBT margin
-
-52,800.0% Much better than peer group: -242,549.9% - Net margin
-
-52,800.0% Much worse than peer group: 49,492.9% - ROE
-
45.1% Much better than peer group: -1.4% - ROA
-
-1,427.0% Much worse than peer group: -59.3% - Asset turnover
-
2.7% Much worse than peer group: 67.6% - FCF margin
-
-5,500.0% Much worse than peer group: 72,877.6% - FCF yield
-198.7% - Efficiency ratio
39,400.0% - Net sales per employee
-
€1.72K - Net income per employee
-
-€909.80K